Navigation Links
Timing of HRT May Influence Heart Risks
Date:4/16/2008

Study found women with risk factors who took it early in menopause did not have diminished vessel function

WEDNESDAY, April 16 (HealthDay News) -- The timing of hormone therapy might determine its effect on a woman's heart.

Specifically, researchers have found that hormone replacement therapy (HRT) administered early in menopause to women with risk factors for heart disease did not diminish the function of the endothelial cells that line the inner walls of the arteries and might even improve it. Endothelial function is a way to measure early heart disease.

"Hormone therapy might not be as bad as was once thought," said Dr. Suzanne Steinbaum, director of Women and Heart Disease at Lenox Hill Hospital in New York City. "It might even be helpful in women with risk factors."

However, there isn't enough evidence to suggest that women should start taking HRT to lower their risk for heart disease, the authors emphasized.

The researchers, from Virginia Commonwealth University Medical Center in Richmond, presented their findings Wednesday at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology annual conference in Atlanta.

A section of the U.S. government-sponsored Women's Health Initiative (WHI), which was designed to look at health issues in postmenopausal women, was halted in 2002, when U.S. researchers found that hormone therapy led to an increased risk of adverse events that included heart attack, stroke, breast cancer and blood clots. The risk depended on whether the woman was taking estrogen alone or estrogen plus progestin, another female hormone.

Since that time, however, a more complex picture has emerged with various factors, including amount of hormone as well as timing, having an effect on risks and benefits of HRT.

Previous research indicated that HRT might have a negative effect on cardiovascular health in women who started therapy long after menopause, versus women taking it sooner after menopause.

Before the WHI, many women took HRT in the belief that it would reduce their risk for heart disease.

For this study, researchers used ultrasound to measure flow-mediated dilation (FMD) in the brachial artery in four groups of postmenopausal women (127 participants total).

FMD measures how well the endothelium functions. The brachial artery is the main artery in the arm.

"Endothelial dysfunction is often associated with risk factors," Steinbaum explained.

There were four groups in all: One comprised of women not on HRT, with no heart disease risk factors and about eight years postmenopausal; women not on HRT but who did have risk factors for coronary disease and a little over nine years postmenopausal; women taking estrogen alone, with risk factors and almost 12 years postmenopausal; and women taking estrogen plus progestin and 7.6 years postmenopausal.

Most women had started HRT about the time menopause started.

Women with risk factors who took HRT saw a slight improvement in FMD and, on the whole, there were no reductions in blood vessel function.

More information

Visit the Women's Health Initiative for more on hormone replacement therapy.



SOURCES: Suzanne Steinbaum, D.O., director, Women and Heart Disease, Lenox Hill Hospital, New York City; April 16, 2008, presentation, American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology annual conference, Atlanta


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. When It Comes to Pregnancy, Timing Is Everything
2. Communicating Clinical Trial Data: Timing Remains Key Challenge for Marketing Teams
3. Mylan Revises Timing of Its Financial Results Conference Call for the Quarter and Nine Months Ended Dec. 31, 2007, to 5 p.m. ET
4. Appropriate timing in the use of breast shields in children can further reduce MDCT radiation dose
5. AUDIO from Medialink and AXA Equitable: Timing Retirement Thinking
6. T cell immunity enhanced by timing of interleukin-7 therapy
7. eDiets.com(R) Updates Timing of Third Quarter 2007 Earnings Conference Call
8. Newly Launched Regence Foundation to Help Transform Health Care and Influence the Nationwide Health Care Debate
9. Genes Influence on Fears Changes Over Time
10. Neighborhood Influences Exercise Levels
11. Prostate size and other neglected factors influence prostate cancer treatment satisfaction
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Timing of HRT May Influence Heart Risks
(Date:10/13/2017)... ... , ... While it’s often important to take certain medications during the night, ... has identified a solution. , She developed a prototype for MOTION LIGHT-UP PILL BOX ... eliminates the need to turn on a light when taking medication during the night, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of ... ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership in ... It also provides a forum to network with elder law attorneys nationwide,” said Somekh. ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: ... “America On The Brink” is the creation of published author, William Nowers. ... As a WWII veteran, he spent thirty years in the Navy. Following ...
(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/22/2017)... 2017  As the latest Obamacare repeal effort moves ... (R-LA) and Lindsey Graham (R-SC) medical ... device industry is in an odd place.  The industry ... excise tax on medical device sales passed along with ... patients, increased visits and hospital customers with the funding ...
(Date:9/19/2017)... ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device ... precise destruction of targeted tissues, announced three leadership team developments today:   ... Stopek, PhD ... ... Veteran medical device executive ...
Breaking Medicine Technology: